Observations placeholder
Xenazine
Identifier
020383
Type of Spiritual Experience
Number of hallucinations: 51
Background
A description of the experience
Tetrabenazine is a drug for the symptomatic treatment of hyperkinetic movement disorder and is marketed under the trade names Nitoman in Canada and Xenazine in New Zealand and some parts of Europe, and is also available in the USA as an orphan drug. On August 15, 2008 the U.S. Food and Drug Administration (FDA) approved the use of tetrabenazine to treat chorea associated with Huntington's disease (HD), the first in the US. The compound has been known since the 1950s.
Side effects
Most common adverse reactions (>10% and at least 5% greater than placebo) were: sedation/somnolence, fatigue, insomnia, depression, suicidal thoughts, akathisia, anxiety and nausea
On Jan, 13, 2017 5,747 people reported to have side effects when taking Xenazine.
Among them, 51 people (0.89%) have Hallucination
Time on Xenazine when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 58.33% | 0.00% | 0.00% | 33.33% | 0.00% | 8.33% | 0.00% |
Gender of people who have Hallucination when taking Xenazine :
| Female | Male | |
| Hallucination | 80.95% | 19.05% |
Age of people who have Hallucination when taking Xenazine :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Hallucination | 0.00% | 0.00% | 6.25% | 0.00% | 18.75% | 0.00% | 56.25% | 18.75% |
On Feb, 3, 2016: 1,529 people reported to have side effects when taking Xenazine. Among them, 391 people (25.57%) have Death.
Time on Xenazine when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 5.23% | 22.88% | 19.61% | 29.41% | 22.22% | 0.00% | 0.65% |
Gender of people who have Death when taking Xenazine :
| Female | Male | |
| Death | 56.64% | 43.36% |
Age of people who have Death when taking Xenazine :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Death | 0.00% | 0.39% | 2.70% | 1.16% | 5.79% | 17.37% | 19.31% | 53.28% |
Top conditions involved for these people :
- Huntington's disease (221 people, 56.52%)
- Dyskinesia (26 people, 6.65%)
- Huntington's chorea (20 people, 5.12%)
- Chorea (10 people, 2.56%)
- Dystonia (8 people, 2.05%)